Home › Neuromuscular Disorders › New York › New York City
Neuromuscular Disorders clinical trials in New York City, NY
5 studies for Neuromuscular Disorders are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
RecruitingPhase 1/2
- NYU Langone, New York
Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
RecruitingObservational study
- Columbia University Irving Medical Center, New York
Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
RecruitingObservational studyHealthy volunteers welcome
- Columbia University Irving Medical Center, New York
Spastic Paraplegia - Centers of Excellence Research Network
RecruitingObservational study
- Columbia University - Irving Medical Center, New York
Measuring Physical Activity With ActivPal
RecruitingObservational studyHealthy volunteers welcome
- Columbia University Irving Medical Center, New York
About Neuromuscular Disorders
Neuromuscular disorders affect the nerves that control your voluntary muscles. Many are genetic. Read about different disorders and treatments.
More about Neuromuscular Disorders on MedlinePlus
Neuromuscular Disorders trials in other cities
- Boston, MA4 studies
- Chicago, IL4 studies
- Philadelphia, PA4 studies
- Richmond, VA3 studies
- Durham, NC3 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.